A Nasdaq-listed biotech firm is betting large on crypto with a $50 million transfer into Hyperliquid’s HYPE token.
In accordance with a June 17 press launch from Eyenovia, Inc., a U.S.-based ophthalmic know-how agency, the corporate has secured $50 million in personal fairness financing to build up over 1 million Hyperliquid (HYPE) tokens. With this transfer, Eyenovia turns into the primary publicly traded U.S. firm to carry HYPE in its treasury and function as a Hyperliquid blockchain validator.
The funding deal contains convertible most well-liked shares and warrants, which may elevate as much as $150 million if totally exercised. Alongside the announcement, Eyenovia named Hyunsu Jung as chief funding officer and board member to supervise the brand new digital asset technique.
“We’re happy to affix the rising variety of corporations adopting cryptocurrency treasury methods,” stated chief govt officer Michael Rowe. “We imagine this transfer helps long-term capital appreciation and shareholder worth.”
Jung referred to as HYPE “essentially the most strong digital asset,” citing Hyperliquid’s fast progress and main onchain income. HYPE ranks because the Twelfth-largest cryptocurrency by market cap, having surged 380% from its April low to an all-time excessive of $45.57 on June 16. At press time, HYPE is buying and selling at $40.24, down 11% from its peak.
Hyperliquid, a high-speed Layer 1 blockchain optimized for perpetuals buying and selling, has seen a wave of adoption. Up to now 30 days, it has accounted for 60% of the whole onchain perps quantity, in line with information from a Dune Analytics dashboard. Month-to-month perps quantity has topped $250 billion, making it a powerful competitor to centralized exchanges comparable to Binance.
Eyenovia plans to execute a staking technique with its HYPE holdings and use Anchorage Digital to safe its property. As well as, the corporate will rebrand to “Hyperion DeFi” and alter its ticker image to HYPD.
Eyenovia will maintain engaged on its flagship Optejet eye remedy gadget, which is anticipated to obtain FDA registration by September, whereas branching out into cryptocurrency. If different public corporations observe Eyenovia’s lead, Hyperliquid may see a pointy enhance in token demand and community results, doubtlessly positioning it as a high 10 blockchain by market capitalization.
